Laura Ziser, Ruben P A van Eijk, Matthew C Kiernan, Allan McRae, Robert D Henderson, David Schultz, Merrilee Needham, Susan Mathers, Pam McCombe, Paul Talman, Steve Vucic
{"title":"Amyotrophic lateral sclerosis established as a multistep process across phenotypes.","authors":"Laura Ziser, Ruben P A van Eijk, Matthew C Kiernan, Allan McRae, Robert D Henderson, David Schultz, Merrilee Needham, Susan Mathers, Pam McCombe, Paul Talman, Steve Vucic","doi":"10.1111/ene.16532","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>Given the accepted multistep process of disease causation in amyotrophic lateral sclerosis (ALS), the present study was undertaken to determine the number of steps required for disease onset across each of the ALS phenotypes.</p><p><strong>Methods: </strong>Clinical and demographic data were prospectively accumulated using the Australian Motor Neurone Disease Registry (2005-2016), and age-specific incidence rates were calculated. Poisson regression was utilized to assess the relationship between log age-specific incidence and log age of onset, with McFadden's R<sup>2</sup> used to assess the goodness of fit of the model.</p><p><strong>Results: </strong>In total, 2647 ALS patients were included, with mean disease-onset age being 62.2 ± 12.1 years. A linear relationship between log incidence and log age was established across ALS phenotypes, with variable slope estimates: bulbar 5.1 (95% confidence interval [CI] 4.6-5.6); cervical 2.7 (95% CI 2.3-3.0); lumbar 3.5 (95% CI 3.2-3.9); flail arm 4.7 (95% CI 3.9-5.5); flail leg 3.6 (95% CI 2.6-4.5); primary lateral sclerosis 2.7 (95% CI 1.8-3.7). Slope estimates were significantly higher in the bulbar compared to the cervical, lumbar and primary lateral sclerosis phenotypes. McFadden's R<sup>2</sup> values were >0.4 for all phenotypes indicating excellent model fit.</p><p><strong>Discussion: </strong>A multistep process has been established across all ALS phenotypes with variable slope estimates, suggesting that the number of steps to develop disease is different across clinical presentations. Identification of mechanisms underlying slope estimate variability could exert pathophysiological significance.</p>","PeriodicalId":11954,"journal":{"name":"European Journal of Neurology","volume":" ","pages":"e16532"},"PeriodicalIF":4.5000,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/ene.16532","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and purpose: Given the accepted multistep process of disease causation in amyotrophic lateral sclerosis (ALS), the present study was undertaken to determine the number of steps required for disease onset across each of the ALS phenotypes.
Methods: Clinical and demographic data were prospectively accumulated using the Australian Motor Neurone Disease Registry (2005-2016), and age-specific incidence rates were calculated. Poisson regression was utilized to assess the relationship between log age-specific incidence and log age of onset, with McFadden's R2 used to assess the goodness of fit of the model.
Results: In total, 2647 ALS patients were included, with mean disease-onset age being 62.2 ± 12.1 years. A linear relationship between log incidence and log age was established across ALS phenotypes, with variable slope estimates: bulbar 5.1 (95% confidence interval [CI] 4.6-5.6); cervical 2.7 (95% CI 2.3-3.0); lumbar 3.5 (95% CI 3.2-3.9); flail arm 4.7 (95% CI 3.9-5.5); flail leg 3.6 (95% CI 2.6-4.5); primary lateral sclerosis 2.7 (95% CI 1.8-3.7). Slope estimates were significantly higher in the bulbar compared to the cervical, lumbar and primary lateral sclerosis phenotypes. McFadden's R2 values were >0.4 for all phenotypes indicating excellent model fit.
Discussion: A multistep process has been established across all ALS phenotypes with variable slope estimates, suggesting that the number of steps to develop disease is different across clinical presentations. Identification of mechanisms underlying slope estimate variability could exert pathophysiological significance.
背景和目的:鉴于肌萎缩性脊髓侧索硬化症(ALS)的致病过程具有公认的多步骤性,本研究旨在确定每种 ALS 表型发病所需的步骤数量:通过澳大利亚运动神经元疾病登记处(2005-2016 年)前瞻性地积累了临床和人口统计学数据,并计算了特定年龄的发病率。利用泊松回归评估对数年龄特异性发病率与对数发病年龄之间的关系,并利用麦克法登 R2 评估模型的拟合度:共纳入了 2647 例 ALS 患者,平均发病年龄为 62.2 ± 12.1 岁。不同 ALS 表型的对数发病率与对数年龄之间呈线性关系,斜率估计值各不相同:球部 5.1(95% 置信区间 [CI] 4.6-5.6);颈部 2.7(95% CI 2.3-3.0);腰部 3.5(95% CI 3.2-3.9);手臂外翻 4.7(95% CI 3.9-5.5);腿部外翻 3.6(95% CI 2.6-4.5);原发性侧索硬化 2.7(95% CI 1.8-3.7)。与颈椎病、腰椎病和原发性侧索硬化症表型相比,球部病变的斜率估计值明显较高。所有表型的麦克法登 R2 值均大于 0.4,表明模型拟合度极佳:讨论:所有 ALS 表型都有一个多步骤过程,但斜率估计值各不相同,这表明不同临床表现的疾病发展步骤数量不同。确定斜率估计值可变性的内在机制可能具有重要的病理生理学意义。
期刊介绍:
The European Journal of Neurology is the official journal of the European Academy of Neurology and covers all areas of clinical and basic research in neurology, including pre-clinical research of immediate translational value for new potential treatments. Emphasis is placed on major diseases of large clinical and socio-economic importance (dementia, stroke, epilepsy, headache, multiple sclerosis, movement disorders, and infectious diseases).